Thurin, Nicolas H. https://orcid.org/0000-0003-3589-0819
Bosco-Levy, Pauline https://orcid.org/0000-0001-9763-5974
Blin, Patrick https://orcid.org/0000-0003-4005-7928
Rouyer, Magali https://orcid.org/0000-0002-2560-4412
Jové, Jérémy
Lamarque, Stéphanie
Lignot, Séverine
Lassalle, Régis https://orcid.org/0000-0001-6726-6215
Abouelfath, Abdelilah
Bignon, Emmanuelle
Diez, Pauline
Gross-Goupil, Marine
Soulié, Michel
Roumiguié, Mathieu
Le Moulec, Sylvestre
Debouverie, Marc
Brochet, Bruno https://orcid.org/0000-0003-3824-2796
Guillemin, Francis
Louapre, Céline https://orcid.org/0000-0002-4987-1531
Maillart, Elisabeth https://orcid.org/0000-0001-7699-0328
Heinzlef, Olivier
Moore, Nicholas https://orcid.org/0000-0003-1212-2817
Droz-Perroteau, Cécile https://orcid.org/0000-0002-7697-1167
Funding for this research was provided by:
Janssen-Cilag
Biogen
Article History
Received: 22 December 2020
Accepted: 15 April 2021
First Online: 1 May 2021
Declarations
:
: In both of the presented examples, rEHR adjudication was used to answer the main research question of the corresponding study for which the approval from the French data protection agency (<i>Commission Nationale Informatique & Libertés</i> – CNIL) was obtained. Moreover, data were fully anonymized before adjudication.
: Not applicable.
: M. G.-G. declares personal fees and non-financial support from Janssen, Sanofi, Astellas, Ipsen, Amgen and Pfizer.M. S. and M. R. declare personal fees and non-financial support from Janssen, Sanofi, Astellas, Ipsen, Amgen, Ferring, and Astra-Zeneca.E. M. declares personal fees and non-financial support from Biogen, Novartis, Roche, Merck, Sanofi-Genzyme.B. B. declares personal fees and non-financial support from Biogen, Genzyme, Bayer, Medday, Actelion, Roche, Celgene, Novartis, Merck.F. G. and M.D. declare personal fees and non-financial support from Biogen.C. L. declares consulting or travel fees from Biogen, Novartis, Roche, Sanofi, Teva and Merck Serono, and research grant from Biogen.O. H. declares personal fees and non-financial support from Biogen, Merck, Novartis, Roche, Genzyme.All remaining authors have declared no conflicts of interest.